Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial

Post time 2026-10-20 20:52:03

journal：Circulation: Cardiovascular Interventions

Authors：J. Dawn Abbott; Nicholas Kassis; Azeem Latib; Richard A. Shlofmitz; Jeffrey W. Moses; William B. Bachinsky; Suhail Dohad; Steven G. Rudick; Robert C. Stoler; Brian K. Jefferson; William J. Nicholson; John D. Altman; Cinthia T. Bateman; Amar Krishnaswamy; Rafael Cavalcante; Robert W. Yeh; Ajay J. Kirtane

Published date：--

DOI：10.1161/circinterventions.125.016289

PDF link：https://www.ahajournals.org/doi/ ... VENTIONS.125.016289

Article link：https://doi.org/10.1161/circinterventions.125.016289

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2026-10-20 20:52:04

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AHA] Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AHA] Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial